[Pathophysiology and clinical aspects of intrahepatic cholestasis].
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001153:Arsphenamine / Q000009:adverse effects; D001647:Bile Acids and Salts / Q000378:metabolism; D001663:Bilirubin / Q000097:blood; D002746:Chlorpromazine / Q000009:adverse effects; D002761:Cholangitis / Q000503:physiopathology; D002779:Cholestasis / Q000139:chemically induced / Q000201:enzymology / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D002784:Cholesterol / Q000096:biosynthesis; D003300:Copper / Q000097:blood; D003513:Cycloheximide / Q000009:adverse effects; D006506:Hepatitis A / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D008105:Liver Cirrhosis, Biliary / Q000503:physiopathology; D008107:Liver Diseases / Q000150:complications; D008777:Methyltestosterone / Q000009:adverse effects; D010634:Phenobarbital / Q000009:adverse effects; D010743:Phospholipids / Q000096:biosynthesis; D051381:Rats; D013861:Thiocyanates / Q000009:adverse effects
D001647:Bile Acids and Salts; D010743:Phospholipids; D013861:Thiocyanates; D001153:Arsphenamine; D003300:Copper; D002784:Cholesterol; D003513:Cycloheximide; D000469:Alkaline Phosphatase; D001663:Bilirubin; D002746:Chlorpromazine; D008777:Methyltestosterone; D010634:Phenobarbital
Pathophysiologie und Klinik der intrahepatischen Cholestase.